Lipid regulating medicines consumption assessment in serbia during the period 2004-2010 year
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: RADONJIC, Vesela (Medicines and Medical Devices Agency of Serbia, National Centre for information on Medicines and medical devices, Belgrade, Serbia)
- Co-author(s): Djuric, D. (Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia)
Lowering the concentration of low density lipoprotein cholesterol and raising high density lipoprotein cholesterol reduces the progression of coronary atherosclerosis and may induce regresion, it stands to reason on significance evaluation of consumption lipid regulating medicines.
The aim of our study was the following consumption The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.